The adoption of device implants is gaining momentum among patient populations globally and is driving implant device technology, including novel biomaterials. Innovation and testing (in vivo and in vitro) of biodegradable materials used in medical implants limit the need for another surgery, support faster recovery and prolong quality life for patients. The expanding geriatric population, increasing prevalence of chronic diseases and consumer preference for minimally invasive surgery are stimulating product advances as medical device players rethink their application and market segment strategies.

“Medical implants based on polymer and biologics such as Poly Ether Ether Ketone (PEEK), Polytetrafluoroethylene (PTFE), Polyester, Polyethylene and Polypropylene for better strength, flexibility and biocompatibility are trends delivering tremendous growth opportunities across this sector,” said Frost & Sullivan Visionary Innovation Industry Analyst Arun Ramesh.

Analysis of Biomedical Textiles Market in US, a new analysis from Frost & Sullivan’s Visionary Science Growth Partnership Service program, discusses how strong growth is occurring across all segments due to:

• Device manufacturers differentiating themselves through new product launches and product enhancements
• Market participants investing in patients’ needs through broader product portfolios, minimally invasive surgical procedures and technology that helps patients recover faster
• Market leaders acquiring peer companies to gain access to technology and geographic expansion